Cargando…
First-in-Human Phase 1 Studies in Oncology: The New Challenge for Investigative Sites
Phase 1 first-in-human studies with anti-cancer products differ from other phase 1 studies in that they are evaluated in patients rather than healthy volunteers. The rationale design of targeted drugs triggers changes in the design of these studies. Patient populations are more precisely defined and...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rambam Health Care Campus
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678815/ https://www.ncbi.nlm.nih.gov/pubmed/23908831 http://dx.doi.org/10.5041/RMMJ.10074 |